



IDENTIFICATION AND QUANTIFICATION OF PHOSPHODIESTERASE-5 INHIBITORS AS 




RAZAN SOUBRA4, AZZA A. GAZY1*, MAY SAAB2, MARWA K. AL JAMAL
Department of Pharmaceutical Technology, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon 
Email: a.ghazi@bau.edu.lb 
3 
Received: 02 Dec 2019, Revised and Accepted: 29 Jan 2020 
ABSTRACT 
Objective: Ultraviolet Visible spectrophotometric was adopted to identify and quantify any adulteration with PDE-5 inhibitors (Sildenafil and 
Tadalafil) in selected dietary supplements used for sexual enhancement in the Lebanese market 
Methods: Nine dietary supplements, randomly collected from Lebanese pharmacies, were screened for Sildenafil and Tadalafil using UV-
spectrophotometry for both qualitative and quantitative detection.  
Results: Tadalafil was detected in one sample at a dose of 59 mg/dosage unit, with the maximal recommended dose being 20 mg. Sildenafil was 
detected in five samples at doses ranging from 11.7 to 188.2 mg/dosage unit, with the maximal recommended dose being 100 mg. 
Conclusion: This study demonstrates that regular analysis of supposed dietary supplements is needed for more effective quality control and health 
promotion. The method described for the extraction, identification and quantification of Tadalafil and Sildenafil would be useful for regulatory 
detection of adulterations. 
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INTRODUCTION 
The popularity of herbal supplements as effective substitutes for 
synthetic drugs has increased worldwide in the recent years [1]. The 
reason for this high popularity is the common belief that herbal 
drugs are safe and can be used without medical supervision [2]. 
Moreover, the majority of patients trust herbal supplements 
manufacturers and believe their claims [3]. Most of these herbal 
preparations are available in the market as over-the-counter (OTC) 
dietary supplements and thus, are subject to food legislation policies 
which does not obligate efficacy studies, safety assessment, or 
quality control [4]. 
Unfortunately, many studies have reported the adulteration of 
herbal products with undeclared pharmaceutical ingredients, even 
at higher levels than the maximum recommended dose, and 
consumers are unaware of these counterfeit products [5]. 
The Food and Drug Administration (FDA) reported 572 adulterated 
dietary supplements between 2007 and 2014 in the United States, of 
which the most common were sexual enhancers (41.6%) [1]. Most of 
these adulterants were phosphodiesterase type five (PDE-5) 
inhibitors (Sildenafil, Tadalafil, Vardenafil and their analogues). The 
majority of reports were from Asian countries (67%), followed by 
Europe (22%) and North America (11%), and the most frequently 
reported adulterants were sildenafil analogues (62%), followed by 
tadalafil (26%) and vardenafil (9%) [6].  
Phosphodiesterase type 5 inhibitors are the leading oral drug for 
pharmacological treatment of erectile dysfunction (ED) [3]. They are 
recommended as the first line of treatment by both the European and 
American urological guidelines [7]. However, they must be used under 
medical supervision as they may predispose the consumer to potentially 
severe drug-drug interactions such as the development of life-
threatening hypotension when used in combination with nitrates [4]. 
It is obvious that the unaware usage of such preparations is 
dangerous as the risk of adulterated drugs use overweighs their 
benefits, especially in patients with co-morbid conditions such as 
cardiovascular complications and diabetes and even polypharmacy 
in older adults pursuing effective and safe alternatives to PDE-5 
inhibitors [2]. 
Up to now, 80 illicit analogues of PDE-5 inhibitors have been 
discovered, and unfortunately, the number is rising [4]. Campbell et 
al. tested 91 herbal products that were mostly in the United States 
and Asia. None of the samples claimed to include synthetic drugs, 
however, PDE-5 inhibitors were detected in 74 of them (81%), most 
of which were Tadalafil and/or Sildenafil, often at amounts higher 
than the maximum approved dose [8]. 
In France, 61% of 150 herbal sexual enhancers marked as 100% 
natural preparations were found to contain PDE-5 inhibitors [9]. 
A study conducted in Malaysia has reported that 82% of 62 products 
that claimed to enhance man’s sexual health, were adulterated with 
one or more PDE-5 inhibitors and analogues, and one of the samples 
was found to contain even 5 different PDE-5 inhibitors [10]. 
In Iran, an analysis of 80 herbal products sold as sexual enhancers 
showed that 22 samples (27.5%) contained at least one undeclared 
pharmaceutical ingredient. Sildenafil was found in 19 samples, and 3 
samples were adulterated with a mixture of tramadol, diazepam, and 
sildenafil [5]. 
In a study conducted in Egypt, five of the most popular food supplements 
used for the treatment of erectile dysfunction were selected for analysis 
from over 50 products available in the Egyptian market (OTC and tele-
advertised). Undeclared sildenafil was detected in all analyzed products 
in amounts reaching to 180 mg per single dose [11]. 
The success of PDE-5 inhibitors for the treatment of ED, the risks they 
propose, and the widespread adulteration, raises the question of 
whether dietary supplements used as sexual enhancers in Lebanon are 
adulterated by synthetic drugs. However, to our knowledge, there 
aren’t any reported analysis of dietary supplements marked for sexual 
enhancement in the Lebanese market.  
Upon screening the literature of the PDE-5 inhibitors (Tadalafil and 
Sildenafil), several analytical methods have been used for their 
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quantitative and qualitative detection. These include; nuclear 
magnetic resonance (NMR) spectroscopy [9], liquid chromatography 
(LC), high performance liquid chromatography (HPLC), ultra-high 
performance liquid chromatography (UHPLC) coupled to 
ultraviolet/diode array detector (UV/DAD) [6], mass spectrometry 
(MS), ultraviolet (UV) spectroscopy, and Fourier transform infrared 
spectroscopy associated with attenuated total reflection (FTIR-ATR) 
[12–14]. 
Spectroscopic methods have been suggested as an on-field 
screening tool to be used by customs that are frequently 
confronted with large numbers of products suspected to be 
adulterated and require analytical inspection. That is because 
these methods are known to be rapid, simple to use, have high 
throughput, and require little sample preparation [12]. For this 
reason, in our work, the analytical method used is UV 
spectrophotometry [15, 16].  
The aim of the present study is to identify and quantify any 
adulteration with PDE-5 inhibitors (sildenafil and tadalafil) in 
selected dietary supplements used for sexual enhancement in the 
Lebanese market using UV spectrophotometric method. 
MATERIALS AND METHODS 
Standards and reagents  
Reference standards of Sildenafil citrate and Tadalafil were certified 
to contain 99.7% (PHARMADEX S. A. L, BEIRUT, LEBANON). 
Methanol of analytical grade (SIGMA-ALDRICH, CHROMASOLV®
Instrumentation 
). 
Nine products randomly purchased from different local pharmacies 
in Beirut were selected for testing. Their dosage from, ingredients 
and manufacturing details are tabulated in table 1. 
Jasco V-730 double beam UV-Vis Spectrophotometer interfaced to a 
computer programmed with Jasco Spectra Manager software was 
used for spectrophotometric measurements, spectral acquisition 
and elaboration. A pair of 1 cm quartz cells were used to measure 
the absorption spectra. 
  
Table 1: Specifications of the tested products 
Sample 
code 
Batch number Expiry date Ingredients  Country 
origin 
Dosage form  
S01 01180121 01/2021 Epimedium, Ginkgo Biloba, Panax Ginseng, Royal Jelly  China  Hard gelatin 
capsule 
S02  (none) 14/06/2020 Ginseng Alijao, root of membranous milk vetch  China  Hard gelatin 
capsule 
S03 120617110622 11/06/2022 Raspberry, Solomonscal Rhizome, Chinese Yam Rhizome, 
Barbary Wolfberry Fruit, Cassia Bark  
China Hard gelatin 
capsule 
S04 20085 11/2020 Epimedium, Tribulus Terrestris, Ginkgo biloba, Hypericum 
perforatum, Cistanche, Crataegus Oxycantha  
Lebanon  Hard gelatin 
capsule 
S05 18022 02/2021 Pomegranate Extract, Broccoli Extract, Curcumin, Bromelain, 
Quercetin, Lycopene, Resveratrol, BioPerine®, Zinc, Copper, 
Selenium  
Lebanon Hard gelatin 
capsule 
S06 0203R 03/2021 Korean Ginseng Extract, Ginkgo Biloba Extract, Vitamin C, 
Vitamin E, Zinc, Selenium, L-Arginine, L-Carnitine, L-Methionine, 
L-Phenylalanine  
England Tablet 
S07 (none) 30/12/2020 Ginkgo Biloba, Epimedium Sagitatum, Tongkat Ali, Panax Ginseng  Spain Tablet 
S08 (none) 30/12/2020 Angelica, Clove Dong Quai Spain Soft Gelatin 
capsule 




Standards and samples preparation 
Preparation of standard stock solution 
Standard stock solutions (1 mg/ml) were prepared by accurately 
weighing and transferring 50 mg Sildenafil citrate or Tadalafil into 
two separate 50ml volumetric flasks. To each flask, 20ml methanol 
were added, sonicated for 5 min, and diluted to the mark with the 
same solvent. 
Preparation of standard working solutions 
Accurate volumes from Sildenafil and Tadalafil standard stock 
solutions were transferred into 50ml volumetric flasks and diluted 
to the mark with methanol, to obtain two different standard working 
solutions of 100 µg/ml each.  
Calibration curve 
Aliquots of the standard working solutions were transferred into 
series of 10ml volumetric flasks, to obtain a calibration set in the 
range of 10–40 µg/ml, using methanol as a solvent. 
Pharmaceutical application 
Four dosage units (powdered tablets, capsule content, or syrup) of 
each product were weighed and mixed. Average weight equivalent 
to one dosage unit was transferred into a 50ml volumetric flask, 
30ml methanol were added and the mixture was sonicated for 20 
min. Another 10ml methanol was then added and sonicated for an 
additional 10 min. The prepared mixture was then filtered and made 
up to 50ml with methanol. From the prepared solution, a volume of 
0.1ml was transferred into 10ml volumetric flask and made up the 
mark with methanol. The absorbance value of this solution was then 
measured in the range of 200–400 nm at 0.5 nm interval, using 
methanol as blank. 
RESULTS AND DISCUSSION 
The UV absorption spectra of Tadalafil (fig. 1) and Sildenafil (fig. 2) 
showed maximum absorption at 284 nm and 291 nm, respectively. 
The UV absorption spectra obtained from the tested products 
showed spectrum corresponding to Tadalafil in sample S01 (fig. 3) 
and spectra corresponding to Sildenafil in samples S02, S03, S04, 
S07, and S09 (fig. 4, 5, 6, 9, and 11, respectively). Whereas samples 
S05, S06, and S08 spectra were not in correspondence to tadalafil or 
sildenafil (fig. 7, 8, and 10, respectively). 
Calibration curves were constructed at a maximum wavelength of 
284 nm and 291 nm for Tadalafil and Sildenafil, respectively (fig. 12 
and 13). Calculations were carried out using absorbance of each 
sample at 284 or 291 nm (Tadalafil or Sildenafil, respectively) in 
correspondence with the calibration curve. The results obtained are 
presented in table 2. 
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Fig. 1: Absorption spectrum of 10 µg/ml standard tadalafil in 
methanol 
 
Fig. 2: Absorption spectrum of 10 µg/ml standard sildenafil in 
methanol 
 
Fig. 3: Absorption spectrum of sample S01  Fig. 4: Absorption spectrum of sample S02 
 
Fig. 5: UV Absorption spectrum of sample S03 
 
Fig. 6: Absorption spectrum of sample S04 
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Fig. 7: Absorption spectrum of sample S05 
 
Fig. 8: Absorption spectrum of sample S06 
 
Fig. 9: Absorption spectrum of sample S07 
 
Fig. 10: Absorption spectrum of sample S08 
 
Fig. 11: Absorption spectrum of sample S09 
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Fig. 12: Calibration curve of tadalafil at λmax
 
=284 nm Fig. 13: Calibration curve of sildenafil at λmax
 
=291 nm 
Table 2: Qualitative and quantitative results of the tested products 
Sample code Adulterant detected Mean Amount per dosage unit (mg)*±SD 
S01 Tadalafil  59.0±0.65 
S02 Sildenafil  140.0±0.33 
S03 Sildenafil 115.0±0.73 
S04 Sildenafil 77.0±0.44 
S05 Negative - 
S06 Negative - 
S07 Sildenafil 11.70±0.32 
S08 Negative - 
S09 Sildenafil 188.20±0.54 
* Mean of samples 5   
 
Tadalafil was detected in one formulation at a dose higher than 20 
mg/dosage unit, the maximal recommended dose. Sildenafil was 
detected in five formulations at doses ranging from 11.7 to 188.2 
mg/dosage unit, with three containing more than 100 mg/dosage unit, 
the maximal recommended dose. These results are in accordance with 
other studies that reported adulteration with PDE-5 inhibitors at 
doses higher than the maximal recommended dose [9, 17, 18]. 
It is worthy to note that the labeled method of administration of 
most of the tested products was 1-2 tablets to be taken 2-3 h before 
sexual intercourse, while some were advised to be taken on daily 
basis. However, to our knowledge, there are no reported data about 
the effectiveness of herbal remedies in improving sexual 
performance when taken as a single dose before sexual intercourse.  
One of the definitions of substandard and falsified (SF) medical 
products is “medical products that deliberately/fraudulently 
misrepresent their identity, composition or source”. Therefore, 
adulterated herbal products are not determined as herbal medicine 
by the World Health Organization (WHO) [19]. 
Several studies showed that PDE-5 inhibitors were detected in 
adulterated herbal products present in the market and advertised on 
the internet to improve sexual performance [12]. In accordance with 
the results of the present study, 6 out of 9 products tested were 
adulterated with Tadalafil or Sildenafil, as shown in table 2. 
The safety profile of such products is of dangerous health concern. 
Several guidelines that were set by the WHO provide practical 
guidance for monitoring the safety of herbal medicines, such as 
pharmacovigilance systems, ‘Good manufacturing practice (GMP)’ for 
dietary supplements and proper labelling of herbal products [20]. 
The European Union (EU) members consider dietary supplements as 
food, and they are subjected to the disposition of the General Food 
Law which set standards for maintaining food safety. Unfortunately, 
in many other countries, this area is not appropriately regulated [7]. 
In Lebanon, a committee affiliated to the Ministry of Public Health 
(MOPH) is responsible for the examination of all the submitted 
applications to permit the manufacturing or importing of herbal 
products and food supplements. Upon submission of applications, 
applicants must provide a certificate of analysis and methods of 
analysis issued by an officially recognized laboratory [21]. Moreover, 
the continuous control in dispensing adulterated herbal products 
inside pharmacies is subject to the inspection of the MOPH, while 
other points of sales remain under the control of the Consumer 
Protection Department of the Ministry of Economy and Trade [22]. 
The high prevalence of adulteration of herbal products, combined 
with the massive growing consumption of dietary supplements, 
necessitate the need to develop rapid and sensitive methods for 
detecting adulterants to protect the public from dangerous 
fraudulent practices.  
CONCLUSION 
Among nine dietary supplements analyzed, six were adulterated 
with PDE-5 inhibitor. Some even contained doses higher than the 
maximal recommended dose. The method described for the 
extraction, identification and quantification of Tadalafil and 
Sildenafil would be useful for regulatory detection of adulterations. 
It is recommended to implement the role of Ministry of Public Health 
in collaboration with the Ministry of Economy and Trade in 
inspecting random samples of the dietary supplement from the point 
of arrival (port), or point of domestic manufacturing, before being 
distributed in the Lebanese market. In addition to routine and 
random inspections as long as available in the Lebanese market. 
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